Lokesh Machines Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 19, 2025, 9:45 pm

Competitors of Lokesh Machines Ltd

All Competitor Stocks of Lokesh Machines Ltd

Quarterly Result

Last Updated: August 20, 2025, 7:40 am

Below is a detailed analysis of the quarterly data for Lokesh Machines Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 48.05 Cr.. The value appears strong and on an upward trend. It has increased from 38.69 Cr. (Mar 2025) to 48.05 Cr., marking an increase of 9.36 Cr..
• For Expenses, as of Jun 2025, the value is 39.44 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 31.37 Cr. (Mar 2025) to 39.44 Cr., marking an increase of 8.07 Cr..
• For Operating Profit, as of Jun 2025, the value is 8.61 Cr.. The value appears strong and on an upward trend. It has increased from 7.32 Cr. (Mar 2025) to 8.61 Cr., marking an increase of 1.29 Cr..
• For OPM %, as of Jun 2025, the value is 17.92%. The value appears to be declining and may need further review. It has decreased from 18.92% (Mar 2025) to 17.92%, marking a decrease of 1.00%.
• For Other Income, as of Jun 2025, the value is 0.28 Cr.. The value appears to be declining and may need further review. It has decreased from 0.46 Cr. (Mar 2025) to 0.28 Cr., marking a decrease of 0.18 Cr..
• For Interest, as of Jun 2025, the value is 4.40 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.88 Cr. (Mar 2025) to 4.40 Cr., marking an increase of 0.52 Cr..
• For Depreciation, as of Jun 2025, the value is 3.77 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.58 Cr. (Mar 2025) to 3.77 Cr., marking an increase of 0.19 Cr..
• For Profit before tax, as of Jun 2025, the value is 0.72 Cr.. The value appears strong and on an upward trend. It has increased from 0.32 Cr. (Mar 2025) to 0.72 Cr., marking an increase of 0.40 Cr..
• For Tax %, as of Jun 2025, the value is 36.11%. The value appears to be improving (decreasing) as expected. It has decreased from 59.38% (Mar 2025) to 36.11%, marking a decrease of 23.27%.
• For Net Profit, as of Jun 2025, the value is 0.46 Cr.. The value appears strong and on an upward trend. It has increased from 0.13 Cr. (Mar 2025) to 0.46 Cr., marking an increase of 0.33 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.24. The value appears strong and on an upward trend. It has increased from 0.07 (Mar 2025) to 0.24, marking an increase of 0.17.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 4:58 am

Growth

Last Updated: September 5, 2025, 9:50 am

Balance Sheet

Last Updated: October 10, 2025, 2:27 pm

Below is a detailed analysis of the balance sheet data for Lokesh Machines Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 19.00 Cr.. The value appears strong and on an upward trend. It has increased from 18.00 Cr. (Mar 2024) to 19.00 Cr., marking an increase of 1.00 Cr..
• For Reserves, as of Mar 2025, the value is 193.00 Cr.. The value appears strong and on an upward trend. It has increased from 177.00 Cr. (Mar 2024) to 193.00 Cr., marking an increase of 16.00 Cr..
• For Borrowings, as of Mar 2025, the value is 134.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 118.00 Cr. (Mar 2024) to 134.00 Cr., marking an increase of 16.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 81.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 77.00 Cr. (Mar 2024) to 81.00 Cr., marking an increase of 4.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 428.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 391.00 Cr. (Mar 2024) to 428.00 Cr., marking an increase of 37.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 204.00 Cr.. The value appears strong and on an upward trend. It has increased from 171.00 Cr. (Mar 2024) to 204.00 Cr., marking an increase of 33.00 Cr..
• For CWIP, as of Mar 2025, the value is 7.00 Cr.. The value appears to be declining and may need further review. It has decreased from 16.00 Cr. (Mar 2024) to 7.00 Cr., marking a decrease of 9.00 Cr..
• For Investments, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 1.00 Cr..
• For Other Assets, as of Mar 2025, the value is 216.00 Cr.. The value appears strong and on an upward trend. It has increased from 202.00 Cr. (Mar 2024) to 216.00 Cr., marking an increase of 14.00 Cr..
• For Total Assets, as of Mar 2025, the value is 428.00 Cr.. The value appears strong and on an upward trend. It has increased from 391.00 Cr. (Mar 2024) to 428.00 Cr., marking an increase of 37.00 Cr..

Notably, the Reserves (193.00 Cr.) exceed the Borrowings (134.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Lokesh Machines Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 0.28. This value is below the healthy minimum of 5. It has decreased from 7.68 (Mar 24) to 0.28, marking a decrease of 7.40.
• For Diluted EPS (Rs.), as of Mar 25, the value is 0.28. This value is below the healthy minimum of 5. It has decreased from 7.68 (Mar 24) to 0.28, marking a decrease of 7.40.
• For Cash EPS (Rs.), as of Mar 25, the value is 7.45. This value is within the healthy range. It has decreased from 12.88 (Mar 24) to 7.45, marking a decrease of 5.43.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 109.98. It has increased from 105.96 (Mar 24) to 109.98, marking an increase of 4.02.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 109.98. It has increased from 105.96 (Mar 24) to 109.98, marking an increase of 4.02.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 117.99. It has decreased from 158.70 (Mar 24) to 117.99, marking a decrease of 40.71.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 15.47. This value is within the healthy range. It has decreased from 22.71 (Mar 24) to 15.47, marking a decrease of 7.24.
• For PBIT / Share (Rs.), as of Mar 25, the value is 8.30. This value is within the healthy range. It has decreased from 17.32 (Mar 24) to 8.30, marking a decrease of 9.02.
• For PBT / Share (Rs.), as of Mar 25, the value is 0.45. This value is within the healthy range. It has decreased from 11.11 (Mar 24) to 0.45, marking a decrease of 10.66.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 2. It has decreased from 7.49 (Mar 24) to 0.27, marking a decrease of 7.22.
• For PBDIT Margin (%), as of Mar 25, the value is 13.11. This value is within the healthy range. It has decreased from 14.30 (Mar 24) to 13.11, marking a decrease of 1.19.
• For PBIT Margin (%), as of Mar 25, the value is 7.03. This value is below the healthy minimum of 10. It has decreased from 10.91 (Mar 24) to 7.03, marking a decrease of 3.88.
• For PBT Margin (%), as of Mar 25, the value is 0.38. This value is below the healthy minimum of 10. It has decreased from 7.00 (Mar 24) to 0.38, marking a decrease of 6.62.
• For Net Profit Margin (%), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 5. It has decreased from 4.71 (Mar 24) to 0.23, marking a decrease of 4.48.
• For Return on Networth / Equity (%), as of Mar 25, the value is 0.25. This value is below the healthy minimum of 15. It has decreased from 7.06 (Mar 24) to 0.25, marking a decrease of 6.81.
• For Return on Capital Employeed (%), as of Mar 25, the value is 5.73. This value is below the healthy minimum of 10. It has decreased from 12.42 (Mar 24) to 5.73, marking a decrease of 6.69.
• For Return On Assets (%), as of Mar 25, the value is 0.12. This value is below the healthy minimum of 5. It has decreased from 3.54 (Mar 24) to 0.12, marking a decrease of 3.42.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.24. This value is within the healthy range. It has increased from 0.23 (Mar 24) to 0.24, marking an increase of 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.62. This value is within the healthy range. It has increased from 0.60 (Mar 24) to 0.62, marking an increase of 0.02.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.55. It has decreased from 0.81 (Mar 24) to 0.55, marking a decrease of 0.26.
• For Current Ratio (X), as of Mar 25, the value is 1.36. This value is below the healthy minimum of 1.5. It has decreased from 1.41 (Mar 24) to 1.36, marking a decrease of 0.05.
• For Quick Ratio (X), as of Mar 25, the value is 0.42. This value is below the healthy minimum of 1. It has decreased from 0.52 (Mar 24) to 0.42, marking a decrease of 0.10.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.06. This value is below the healthy minimum of 4. It has decreased from 1.49 (Mar 24) to 1.06, marking a decrease of 0.43.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 1.97. This value is below the healthy minimum of 3. It has decreased from 3.66 (Mar 24) to 1.97, marking a decrease of 1.69.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.04. This value is below the healthy minimum of 3. It has decreased from 2.21 (Mar 24) to 1.04, marking a decrease of 1.17.
• For Enterprise Value (Cr.), as of Mar 25, the value is 434.20. It has decreased from 794.50 (Mar 24) to 434.20, marking a decrease of 360.30.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.90. This value is within the healthy range. It has decreased from 2.71 (Mar 24) to 1.90, marking a decrease of 0.81.
• For EV / EBITDA (X), as of Mar 25, the value is 14.50. This value is within the healthy range. It has decreased from 18.91 (Mar 24) to 14.50, marking a decrease of 4.41.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.36. This value is within the healthy range. It has decreased from 2.33 (Mar 24) to 1.36, marking a decrease of 0.97.
• For Price / BV (X), as of Mar 25, the value is 1.46. This value is within the healthy range. It has decreased from 3.49 (Mar 24) to 1.46, marking a decrease of 2.03.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.36. This value is within the healthy range. It has decreased from 2.33 (Mar 24) to 1.36, marking a decrease of 0.97.
• For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 24) to 0.00, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness